Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · IEX Real-Time Price · USD
2.000
+0.200 (11.11%)
At close: May 17, 2024, 4:00 PM
2.010
+0.010 (0.50%)
After-hours: May 17, 2024, 7:52 PM EDT
Context Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CNTX stock have an average target of 6.50, with a low estimate of 4.50 and a high estimate of 10. The average target predicts an increase of 225.00% from the current stock price of 2.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CNTX stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $4.5 | Buy | Initiates | $4.5 | +125.00% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $5 | Strong Buy | Maintains | $4 → $5 | +150.00% | May 9, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $4 → $10 | Strong Buy | Maintains | $4 → $10 | +400.00% | May 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $4 | Strong Buy | Maintains | $5 → $4 | +100.00% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $5 | Hold → Strong Buy | Upgrades | $5 | +150.00% | Nov 1, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.32
from -1.50
EPS Next Year
-0.72
from -1.32
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | n/a | 6.9M |
| Avg | n/a | n/a | n/a | n/a | 3.4M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.29 | -0.75 | -0.78 | -0.82 | -0.85 |
| Avg | -1.32 | -0.72 | -0.75 | -1.18 | -1.23 |
| Low | -1.33 | -0.70 | -0.73 | -1.50 | -1.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.